img

Global Swine Influenza Vaccines Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Swine Influenza Vaccines Market Insights, Forecast to 2034

Vaccines have been developed to protect against the virus that causes swine flu. There are two different brands of vaccine – Pandemrix and Celvapan.
Global Swine Influenza Vaccines market is expected to reach to US$ 130 million in 2024, with a positive growth of %, compared with US$ 124 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Swine Influenza Vaccines industry is evaluated to reach US$ 167.4 million in 2029. The CAGR will be 4.3% during 2024 to 2029.
The swine influenza vaccines market is experiencing significant growth due to the increasing prevalence of swine influenza and the rising demand for efficient disease prevention in swine populations. Swine influenza vaccines play a vital role in controlling and preventing respiratory diseases in pigs. The market is driven by factors such as the growth of the swine industry, the need for improved animal health and welfare, and the implementation of strict biosecurity measures. Advancements in vaccine development, including the availability of more effective and targeted vaccines, are further contributing to market growth. However, challenges such as the emergence of new strains of swine influenza virus and the requirement for periodic vaccine updates may impact market expansion. With the continuous focus on swine health management, disease prevention, and sustainable swine production, the swine influenza vaccines market is expected to witness sustained growth in the coming years.
Report Covers
This report presents an overview of global Swine Influenza Vaccines market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Swine Influenza Vaccines market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Chengdu TECBOND
Green Cross Veterinary
Hipra
MSD Animal Health (Merck)
Zoetis
CAHIC
Boehringer Ingelheim
Ceva
Ringpu Biology
DHN
Segment by Type
Live Vaccines
Killed Vaccines

Segment by Application


Commodity Pig
Breeding Pig

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
UK
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Swine Influenza Vaccines plant distribution, commercial date of Swine Influenza Vaccines, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Swine Influenza Vaccines introduction, etc. Swine Influenza Vaccines Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of Swine Influenza Vaccines
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Swine Influenza Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Swine Influenza Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Live Vaccines
1.2.3 Killed Vaccines
1.3 Market by Application
1.3.1 Global Swine Influenza Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Commodity Pig
1.3.3 Breeding Pig
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Swine Influenza Vaccines Sales Estimates and Forecasts 2018-2029
2.2 Global Swine Influenza Vaccines Revenue by Region
2.2.1 Global Swine Influenza Vaccines Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Swine Influenza Vaccines Revenue by Region (2018-2024)
2.2.3 Global Swine Influenza Vaccines Revenue by Region (2024-2029)
2.2.4 Global Swine Influenza Vaccines Revenue Market Share by Region (2018-2029)
2.3 Global Swine Influenza Vaccines Sales Estimates and Forecasts 2018-2029
2.4 Global Swine Influenza Vaccines Sales by Region
2.4.1 Global Swine Influenza Vaccines Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Swine Influenza Vaccines Sales by Region (2018-2024)
2.4.3 Global Swine Influenza Vaccines Sales by Region (2024-2029)
2.4.4 Global Swine Influenza Vaccines Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Swine Influenza Vaccines Sales by Manufacturers
3.1.1 Global Swine Influenza Vaccines Sales by Manufacturers (2018-2024)
3.1.2 Global Swine Influenza Vaccines Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Swine Influenza Vaccines in 2022
3.2 Global Swine Influenza Vaccines Revenue by Manufacturers
3.2.1 Global Swine Influenza Vaccines Revenue by Manufacturers (2018-2024)
3.2.2 Global Swine Influenza Vaccines Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Swine Influenza Vaccines Revenue in 2022
3.3 Global Key Players of Swine Influenza Vaccines, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Swine Influenza Vaccines Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Swine Influenza Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Swine Influenza Vaccines, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Swine Influenza Vaccines, Product Offered and Application
3.8 Global Key Manufacturers of Swine Influenza Vaccines, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Swine Influenza Vaccines Sales by Type
4.1.1 Global Swine Influenza Vaccines Historical Sales by Type (2018-2024)
4.1.2 Global Swine Influenza Vaccines Forecasted Sales by Type (2024-2029)
4.1.3 Global Swine Influenza Vaccines Sales Market Share by Type (2018-2029)
4.2 Global Swine Influenza Vaccines Revenue by Type
4.2.1 Global Swine Influenza Vaccines Historical Revenue by Type (2018-2024)
4.2.2 Global Swine Influenza Vaccines Forecasted Revenue by Type (2024-2029)
4.2.3 Global Swine Influenza Vaccines Revenue Market Share by Type (2018-2029)
4.3 Global Swine Influenza Vaccines Price by Type
4.3.1 Global Swine Influenza Vaccines Price by Type (2018-2024)
4.3.2 Global Swine Influenza Vaccines Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Swine Influenza Vaccines Sales by Application
5.1.1 Global Swine Influenza Vaccines Historical Sales by Application (2018-2024)
5.1.2 Global Swine Influenza Vaccines Forecasted Sales by Application (2024-2029)
5.1.3 Global Swine Influenza Vaccines Sales Market Share by Application (2018-2029)
5.2 Global Swine Influenza Vaccines Revenue by Application
5.2.1 Global Swine Influenza Vaccines Historical Revenue by Application (2018-2024)
5.2.2 Global Swine Influenza Vaccines Forecasted Revenue by Application (2024-2029)
5.2.3 Global Swine Influenza Vaccines Revenue Market Share by Application (2018-2029)
5.3 Global Swine Influenza Vaccines Price by Application
5.3.1 Global Swine Influenza Vaccines Price by Application (2018-2024)
5.3.2 Global Swine Influenza Vaccines Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Swine Influenza Vaccines Market Size by Type
6.1.1 US & Canada Swine Influenza Vaccines Sales by Type (2018-2029)
6.1.2 US & Canada Swine Influenza Vaccines Revenue by Type (2018-2029)
6.2 US & Canada Swine Influenza Vaccines Market Size by Application
6.2.1 US & Canada Swine Influenza Vaccines Sales by Application (2018-2029)
6.2.2 US & Canada Swine Influenza Vaccines Revenue by Application (2018-2029)
6.3 US & Canada Swine Influenza Vaccines Market Size by Country
6.3.1 US & Canada Swine Influenza Vaccines Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Swine Influenza Vaccines Sales by Country (2018-2029)
6.3.3 US & Canada Swine Influenza Vaccines Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Swine Influenza Vaccines Market Size by Type
7.1.1 Europe Swine Influenza Vaccines Sales by Type (2018-2029)
7.1.2 Europe Swine Influenza Vaccines Revenue by Type (2018-2029)
7.2 Europe Swine Influenza Vaccines Market Size by Application
7.2.1 Europe Swine Influenza Vaccines Sales by Application (2018-2029)
7.2.2 Europe Swine Influenza Vaccines Revenue by Application (2018-2029)
7.3 Europe Swine Influenza Vaccines Market Size by Country
7.3.1 Europe Swine Influenza Vaccines Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Swine Influenza Vaccines Sales by Country (2018-2029)
7.3.3 Europe Swine Influenza Vaccines Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 UK
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Swine Influenza Vaccines Market Size
8.1.1 China Swine Influenza Vaccines Sales (2018-2029)
8.1.2 China Swine Influenza Vaccines Revenue (2018-2029)
8.2 China Swine Influenza Vaccines Market Size by Application
8.2.1 China Swine Influenza Vaccines Sales by Application (2018-2029)
8.2.2 China Swine Influenza Vaccines Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Swine Influenza Vaccines Market Size by Type
9.1.1 Asia Swine Influenza Vaccines Sales by Type (2018-2029)
9.1.2 Asia Swine Influenza Vaccines Revenue by Type (2018-2029)
9.2 Asia Swine Influenza Vaccines Market Size by Application
9.2.1 Asia Swine Influenza Vaccines Sales by Application (2018-2029)
9.2.2 Asia Swine Influenza Vaccines Revenue by Application (2018-2029)
9.3 Asia Swine Influenza Vaccines Sales by Region
9.3.1 Asia Swine Influenza Vaccines Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Swine Influenza Vaccines Revenue by Region (2018-2029)
9.3.3 Asia Swine Influenza Vaccines Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Swine Influenza Vaccines Market Size by Type
10.1.1 Middle East, Africa and Latin America Swine Influenza Vaccines Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Swine Influenza Vaccines Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Swine Influenza Vaccines Market Size by Application
10.2.1 Middle East, Africa and Latin America Swine Influenza Vaccines Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Swine Influenza Vaccines Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Swine Influenza Vaccines Sales by Country
10.3.1 Middle East, Africa and Latin America Swine Influenza Vaccines Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Swine Influenza Vaccines Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Swine Influenza Vaccines Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Chengdu TECBOND
11.1.1 Chengdu TECBOND Company Information
11.1.2 Chengdu TECBOND Overview
11.1.3 Chengdu TECBOND Swine Influenza Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Chengdu TECBOND Swine Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Chengdu TECBOND Recent Developments
11.2 Green Cross Veterinary
11.2.1 Green Cross Veterinary Company Information
11.2.2 Green Cross Veterinary Overview
11.2.3 Green Cross Veterinary Swine Influenza Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Green Cross Veterinary Swine Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Green Cross Veterinary Recent Developments
11.3 Hipra
11.3.1 Hipra Company Information
11.3.2 Hipra Overview
11.3.3 Hipra Swine Influenza Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Hipra Swine Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Hipra Recent Developments
11.4 MSD Animal Health (Merck)
11.4.1 MSD Animal Health (Merck) Company Information
11.4.2 MSD Animal Health (Merck) Overview
11.4.3 MSD Animal Health (Merck) Swine Influenza Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 MSD Animal Health (Merck) Swine Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 MSD Animal Health (Merck) Recent Developments
11.5 Zoetis
11.5.1 Zoetis Company Information
11.5.2 Zoetis Overview
11.5.3 Zoetis Swine Influenza Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Zoetis Swine Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Zoetis Recent Developments
11.6 CAHIC
11.6.1 CAHIC Company Information
11.6.2 CAHIC Overview
11.6.3 CAHIC Swine Influenza Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 CAHIC Swine Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 CAHIC Recent Developments
11.7 Boehringer Ingelheim
11.7.1 Boehringer Ingelheim Company Information
11.7.2 Boehringer Ingelheim Overview
11.7.3 Boehringer Ingelheim Swine Influenza Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Boehringer Ingelheim Swine Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Boehringer Ingelheim Recent Developments
11.8 Ceva
11.8.1 Ceva Company Information
11.8.2 Ceva Overview
11.8.3 Ceva Swine Influenza Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Ceva Swine Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Ceva Recent Developments
11.9 Ringpu Biology
11.9.1 Ringpu Biology Company Information
11.9.2 Ringpu Biology Overview
11.9.3 Ringpu Biology Swine Influenza Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Ringpu Biology Swine Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Ringpu Biology Recent Developments
11.10 DHN
11.10.1 DHN Company Information
11.10.2 DHN Overview
11.10.3 DHN Swine Influenza Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 DHN Swine Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 DHN Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Swine Influenza Vaccines Industry Chain Analysis
12.2 Swine Influenza Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Swine Influenza Vaccines Production Mode & Process
12.4 Swine Influenza Vaccines Sales and Marketing
12.4.1 Swine Influenza Vaccines Sales Channels
12.4.2 Swine Influenza Vaccines Distributors
12.5 Swine Influenza Vaccines Customers
13 Market Dynamics
13.1 Swine Influenza Vaccines Industry Trends
13.2 Swine Influenza Vaccines Market Drivers
13.3 Swine Influenza Vaccines Market Challenges
13.4 Swine Influenza Vaccines Market Restraints
14 Key Findings in The Global Swine Influenza Vaccines Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Swine Influenza Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Live Vaccines
Table 3. Major Manufacturers of Killed Vaccines
Table 4. Global Swine Influenza Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Swine Influenza Vaccines Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Swine Influenza Vaccines Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Swine Influenza Vaccines Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Swine Influenza Vaccines Revenue Market Share by Region (2018-2024)
Table 9. Global Swine Influenza Vaccines Revenue Market Share by Region (2024-2029)
Table 10. Global Swine Influenza Vaccines Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Swine Influenza Vaccines Sales by Region (2018-2024) & (M Units)
Table 12. Global Swine Influenza Vaccines Sales by Region (2024-2029) & (M Units)
Table 13. Global Swine Influenza Vaccines Sales Market Share by Region (2018-2024)
Table 14. Global Swine Influenza Vaccines Sales Market Share by Region (2024-2029)
Table 15. Global Swine Influenza Vaccines Sales by Manufacturers (2018-2024) & (M Units)
Table 16. Global Swine Influenza Vaccines Sales Share by Manufacturers (2018-2024)
Table 17. Global Swine Influenza Vaccines Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Swine Influenza Vaccines Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Swine Influenza Vaccines, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Swine Influenza Vaccines Price by Manufacturers 2018-2024 (USD/K Unit)
Table 21. Global Swine Influenza Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Swine Influenza Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Swine Influenza Vaccines as of 2022)
Table 23. Global Key Manufacturers of Swine Influenza Vaccines, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Swine Influenza Vaccines, Product Offered and Application
Table 25. Global Key Manufacturers of Swine Influenza Vaccines, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Swine Influenza Vaccines Sales by Type (2018-2024) & (M Units)
Table 28. Global Swine Influenza Vaccines Sales by Type (2024-2029) & (M Units)
Table 29. Global Swine Influenza Vaccines Sales Share by Type (2018-2024)
Table 30. Global Swine Influenza Vaccines Sales Share by Type (2024-2029)
Table 31. Global Swine Influenza Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Swine Influenza Vaccines Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Swine Influenza Vaccines Revenue Share by Type (2018-2024)
Table 34. Global Swine Influenza Vaccines Revenue Share by Type (2024-2029)
Table 35. Swine Influenza Vaccines Price by Type (2018-2024) & (USD/K Unit)
Table 36. Global Swine Influenza Vaccines Price Forecast by Type (2024-2029) & (USD/K Unit)
Table 37. Global Swine Influenza Vaccines Sales by Application (2018-2024) & (M Units)
Table 38. Global Swine Influenza Vaccines Sales by Application (2024-2029) & (M Units)
Table 39. Global Swine Influenza Vaccines Sales Share by Application (2018-2024)
Table 40. Global Swine Influenza Vaccines Sales Share by Application (2024-2029)
Table 41. Global Swine Influenza Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Swine Influenza Vaccines Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Swine Influenza Vaccines Revenue Share by Application (2018-2024)
Table 44. Global Swine Influenza Vaccines Revenue Share by Application (2024-2029)
Table 45. Swine Influenza Vaccines Price by Application (2018-2024) & (USD/K Unit)
Table 46. Global Swine Influenza Vaccines Price Forecast by Application (2024-2029) & (USD/K Unit)
Table 47. US & Canada Swine Influenza Vaccines Sales by Type (2018-2024) & (M Units)
Table 48. US & Canada Swine Influenza Vaccines Sales by Type (2024-2029) & (M Units)
Table 49. US & Canada Swine Influenza Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Swine Influenza Vaccines Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Swine Influenza Vaccines Sales by Application (2018-2024) & (M Units)
Table 52. US & Canada Swine Influenza Vaccines Sales by Application (2024-2029) & (M Units)
Table 53. US & Canada Swine Influenza Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Swine Influenza Vaccines Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Swine Influenza Vaccines Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Swine Influenza Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Swine Influenza Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Swine Influenza Vaccines Sales by Country (2018-2024) & (M Units)
Table 59. US & Canada Swine Influenza Vaccines Sales by Country (2024-2029) & (M Units)
Table 60. Europe Swine Influenza Vaccines Sales by Type (2018-2024) & (M Units)
Table 61. Europe Swine Influenza Vaccines Sales by Type (2024-2029) & (M Units)
Table 62. Europe Swine Influenza Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Swine Influenza Vaccines Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Swine Influenza Vaccines Sales by Application (2018-2024) & (M Units)
Table 65. Europe Swine Influenza Vaccines Sales by Application (2024-2029) & (M Units)
Table 66. Europe Swine Influenza Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Swine Influenza Vaccines Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Swine Influenza Vaccines Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Swine Influenza Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Swine Influenza Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Swine Influenza Vaccines Sales by Country (2018-2024) & (M Units)
Table 72. Europe Swine Influenza Vaccines Sales by Country (2024-2029) & (M Units)
Table 73. China Swine Influenza Vaccines Sales by Type (2018-2024) & (M Units)
Table 74. China Swine Influenza Vaccines Sales by Type (2024-2029) & (M Units)
Table 75. China Swine Influenza Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Swine Influenza Vaccines Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Swine Influenza Vaccines Sales by Application (2018-2024) & (M Units)
Table 78. China Swine Influenza Vaccines Sales by Application (2024-2029) & (M Units)
Table 79. China Swine Influenza Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Swine Influenza Vaccines Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Swine Influenza Vaccines Sales by Type (2018-2024) & (M Units)
Table 82. Asia Swine Influenza Vaccines Sales by Type (2024-2029) & (M Units)
Table 83. Asia Swine Influenza Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Swine Influenza Vaccines Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Swine Influenza Vaccines Sales by Application (2018-2024) & (M Units)
Table 86. Asia Swine Influenza Vaccines Sales by Application (2024-2029) & (M Units)
Table 87. Asia Swine Influenza Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Swine Influenza Vaccines Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Swine Influenza Vaccines Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Swine Influenza Vaccines Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Swine Influenza Vaccines Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Swine Influenza Vaccines Sales by Region (2018-2024) & (M Units)
Table 93. Asia Swine Influenza Vaccines Sales by Region (2024-2029) & (M Units)
Table 94. Middle East, Africa and Latin America Swine Influenza Vaccines Sales by Type (2018-2024) & (M Units)
Table 95. Middle East, Africa and Latin America Swine Influenza Vaccines Sales by Type (2024-2029) & (M Units)
Table 96. Middle East, Africa and Latin America Swine Influenza Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Swine Influenza Vaccines Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Swine Influenza Vaccines Sales by Application (2018-2024) & (M Units)
Table 99. Middle East, Africa and Latin America Swine Influenza Vaccines Sales by Application (2024-2029) & (M Units)
Table 100. Middle East, Africa and Latin America Swine Influenza Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Swine Influenza Vaccines Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Swine Influenza Vaccines Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Swine Influenza Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Swine Influenza Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Swine Influenza Vaccines Sales by Country (2018-2024) & (M Units)
Table 106. Middle East, Africa and Latin America Swine Influenza Vaccines Sales by Country (2024-2029) & (M Units)
Table 107. Chengdu TECBOND Company Information
Table 108. Chengdu TECBOND Description and Major Businesses
Table 109. Chengdu TECBOND Swine Influenza Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 110. Chengdu TECBOND Swine Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Chengdu TECBOND Recent Developments
Table 112. Green Cross Veterinary Company Information
Table 113. Green Cross Veterinary Description and Major Businesses
Table 114. Green Cross Veterinary Swine Influenza Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 115. Green Cross Veterinary Swine Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Green Cross Veterinary Recent Developments
Table 117. Hipra Company Information
Table 118. Hipra Description and Major Businesses
Table 119. Hipra Swine Influenza Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 120. Hipra Swine Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Hipra Recent Developments
Table 122. MSD Animal Health (Merck) Company Information
Table 123. MSD Animal Health (Merck) Description and Major Businesses
Table 124. MSD Animal Health (Merck) Swine Influenza Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 125. MSD Animal Health (Merck) Swine Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. MSD Animal Health (Merck) Recent Developments
Table 127. Zoetis Company Information
Table 128. Zoetis Description and Major Businesses
Table 129. Zoetis Swine Influenza Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 130. Zoetis Swine Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Zoetis Recent Developments
Table 132. CAHIC Company Information
Table 133. CAHIC Description and Major Businesses
Table 134. CAHIC Swine Influenza Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 135. CAHIC Swine Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. CAHIC Recent Developments
Table 137. Boehringer Ingelheim Company Information
Table 138. Boehringer Ingelheim Description and Major Businesses
Table 139. Boehringer Ingelheim Swine Influenza Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 140. Boehringer Ingelheim Swine Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Boehringer Ingelheim Recent Developments
Table 142. Ceva Company Information
Table 143. Ceva Description and Major Businesses
Table 144. Ceva Swine Influenza Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 145. Ceva Swine Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Ceva Recent Developments
Table 147. Ringpu Biology Company Information
Table 148. Ringpu Biology Description and Major Businesses
Table 149. Ringpu Biology Swine Influenza Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 150. Ringpu Biology Swine Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Ringpu Biology Recent Developments
Table 152. DHN Company Information
Table 153. DHN Description and Major Businesses
Table 154. DHN Swine Influenza Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 155. DHN Swine Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. DHN Recent Developments
Table 157. Key Raw Materials Lists
Table 158. Raw Materials Key Suppliers Lists
Table 159. Swine Influenza Vaccines Distributors List
Table 160. Swine Influenza Vaccines Customers List
Table 161. Swine Influenza Vaccines Market Trends
Table 162. Swine Influenza Vaccines Market Drivers
Table 163. Swine Influenza Vaccines Market Challenges
Table 164. Swine Influenza Vaccines Market Restraints
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
List of Figures
Figure 1. Swine Influenza Vaccines Product Picture
Figure 2. Global Swine Influenza Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Swine Influenza Vaccines Market Share by Type in 2022 & 2029
Figure 4. Live Vaccines Product Picture
Figure 5. Killed Vaccines Product Picture
Figure 6. Global Swine Influenza Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Swine Influenza Vaccines Market Share by Application in 2022 & 2029
Figure 8. Commodity Pig
Figure 9. Breeding Pig
Figure 10. Swine Influenza Vaccines Report Years Considered
Figure 11. Global Swine Influenza Vaccines Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Swine Influenza Vaccines Revenue 2018-2029 (US$ Million)
Figure 13. Global Swine Influenza Vaccines Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 14. Global Swine Influenza Vaccines Revenue Market Share by Region (2018-2029)
Figure 15. Global Swine Influenza Vaccines Sales 2018-2029 ((M Units)
Figure 16. Global Swine Influenza Vaccines Sales Market Share by Region (2018-2029)
Figure 17. US & Canada Swine Influenza Vaccines Sales YoY (2018-2029) & (M Units)
Figure 18. US & Canada Swine Influenza Vaccines Revenue YoY (2018-2029) & (US$ Million)
Figure 19. Europe Swine Influenza Vaccines Sales YoY (2018-2029) & (M Units)
Figure 20. Europe Swine Influenza Vaccines Revenue YoY (2018-2029) & (US$ Million)
Figure 21. China Swine Influenza Vaccines Sales YoY (2018-2029) & (M Units)
Figure 22. China Swine Influenza Vaccines Revenue YoY (2018-2029) & (US$ Million)
Figure 23. Asia (excluding China) Swine Influenza Vaccines Sales YoY (2018-2029) & (M Units)
Figure 24. Asia (excluding China) Swine Influenza Vaccines Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Swine Influenza Vaccines Sales YoY (2018-2029) & (M Units)
Figure 26. Middle East, Africa and Latin America Swine Influenza Vaccines Revenue YoY (2018-2029) & (US$ Million)
Figure 27. The Swine Influenza Vaccines Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 28. The Top 5 and 10 Largest Manufacturers of Swine Influenza Vaccines in the World: Market Share by Swine Influenza Vaccines Revenue in 2022
Figure 29. Global Swine Influenza Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Global Swine Influenza Vaccines Sales Market Share by Type (2018-2029)
Figure 31. Global Swine Influenza Vaccines Revenue Market Share by Type (2018-2029)
Figure 32. Global Swine Influenza Vaccines Sales Market Share by Application (2018-2029)
Figure 33. Global Swine Influenza Vaccines Revenue Market Share by Application (2018-2029)
Figure 34. US & Canada Swine Influenza Vaccines Sales Market Share by Type (2018-2029)
Figure 35. US & Canada Swine Influenza Vaccines Revenue Market Share by Type (2018-2029)
Figure 36. US & Canada Swine Influenza Vaccines Sales Market Share by Application (2018-2029)
Figure 37. US & Canada Swine Influenza Vaccines Revenue Market Share by Application (2018-2029)
Figure 38. US & Canada Swine Influenza Vaccines Revenue Share by Country (2018-2029)
Figure 39. US & Canada Swine Influenza Vaccines Sales Share by Country (2018-2029)
Figure 40. U.S. Swine Influenza Vaccines Revenue (2018-2029) & (US$ Million)
Figure 41. Canada Swine Influenza Vaccines Revenue (2018-2029) & (US$ Million)
Figure 42. Europe Swine Influenza Vaccines Sales Market Share by Type (2018-2029)
Figure 43. Europe Swine Influenza Vaccines Revenue Market Share by Type (2018-2029)
Figure 44. Europe Swine Influenza Vaccines Sales Market Share by Application (2018-2029)
Figure 45. Europe Swine Influenza Vaccines Revenue Market Share by Application (2018-2029)
Figure 46. Europe Swine Influenza Vaccines Revenue Share by Country (2018-2029)
Figure 47. Europe Swine Influenza Vaccines Sales Share by Country (2018-2029)
Figure 48. Germany Swine Influenza Vaccines Revenue (2018-2029) & (US$ Million)
Figure 49. France Swine Influenza Vaccines Revenue (2018-2029) & (US$ Million)
Figure 50. UK Swine Influenza Vaccines Revenue (2018-2029) & (US$ Million)
Figure 51. Italy Swine Influenza Vaccines Revenue (2018-2029) & (US$ Million)
Figure 52. Russia Swine Influenza Vaccines Revenue (2018-2029) & (US$ Million)
Figure 53. China Swine Influenza Vaccines Sales Market Share by Type (2018-2029)
Figure 54. China Swine Influenza Vaccines Revenue Market Share by Type (2018-2029)
Figure 55. China Swine Influenza Vaccines Sales Market Share by Application (2018-2029)
Figure 56. China Swine Influenza Vaccines Revenue Market Share by Application (2018-2029)
Figure 57. Asia Swine Influenza Vaccines Sales Market Share by Type (2018-2029)
Figure 58. Asia Swine Influenza Vaccines Revenue Market Share by Type (2018-2029)
Figure 59. Asia Swine Influenza Vaccines Sales Market Share by Application (2018-2029)
Figure 60. Asia Swine Influenza Vaccines Revenue Market Share by Application (2018-2029)
Figure 61. Asia Swine Influenza Vaccines Revenue Share by Region (2018-2029)
Figure 62. Asia Swine Influenza Vaccines Sales Share by Region (2018-2029)
Figure 63. Japan Swine Influenza Vaccines Revenue (2018-2029) & (US$ Million)
Figure 64. South Korea Swine Influenza Vaccines Revenue (2018-2029) & (US$ Million)
Figure 65. China Taiwan Swine Influenza Vaccines Revenue (2018-2029) & (US$ Million)
Figure 66. Southeast Asia Swine Influenza Vaccines Revenue (2018-2029) & (US$ Million)
Figure 67. India Swine Influenza Vaccines Revenue (2018-2029) & (US$ Million)
Figure 68. Middle East, Africa and Latin America Swine Influenza Vaccines Sales Market Share by Type (2018-2029)
Figure 69. Middle East, Africa and Latin America Swine Influenza Vaccines Revenue Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Swine Influenza Vaccines Sales Market Share by Application (2018-2029)
Figure 71. Middle East, Africa and Latin America Swine Influenza Vaccines Revenue Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Swine Influenza Vaccines Revenue Share by Country (2018-2029)
Figure 73. Middle East, Africa and Latin America Swine Influenza Vaccines Sales Share by Country (2018-2029)
Figure 74. Brazil Swine Influenza Vaccines Revenue (2018-2029) & (US$ Million)
Figure 75. Mexico Swine Influenza Vaccines Revenue (2018-2029) & (US$ Million)
Figure 76. Turkey Swine Influenza Vaccines Revenue (2018-2029) & (US$ Million)
Figure 77. Israel Swine Influenza Vaccines Revenue (2018-2029) & (US$ Million)
Figure 78. GCC Countries Swine Influenza Vaccines Revenue (2018-2029) & (US$ Million)
Figure 79. Swine Influenza Vaccines Value Chain
Figure 80. Swine Influenza Vaccines Production Process
Figure 81. Channels of Distribution
Figure 82. Distributors Profiles
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries